Multi-Leu peptide (triacetate)
Multi-Leu peptide (ML-peptide) triacetate is a potent inhibitor of PACE4 (Ki=22 nM) . Multi-Leu peptide triacetate can competitively bind to the active site of PACE4 by simulating the substrate sequence of PACE4, thereby inhibiting its catalytic activity. Multi-Leu peptide triacetate can be used to study the specific mechanism of PACE4 in the development of prostate cancer[1].
Product Specifications
Product Name Alternative
ML-peptide, Multi-Leucine (ML) -peptide (triacetate)
UNSPSC
12352209
Target
Autophagy
Related Pathways
Autophagy
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Purity
98.64
Smiles
Molecular Formula
C55H106N16O15
Molecular Weight
1231.53
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P10422A/Multi-Leu-peptide-triacetate-SDS-MedChemExpress.pdf
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items